Genetic Polymorphism of the Acute Lymphoblastic Leukaemia and Hyperhomocysteinemia its Relation with the for a Group of Children in the East of Algeria

Authors: Yahia Massinissa, Kalla A, Yahia M, Benbia S

Abstract:

A lot of recent research have spoken on the relation between the increase of the homocysteinemia and some kinds of cancer . For that, our study was based on the research of a possible relation between the increase of the concentration of this amino-acid in the plasma and the appearance of the disease of the Acute Lymphoblastic Leukaemia in a part of Algerian children with Berber origin in the East of Algeria . The study has done on 47 ill persons with an average age of (09±06 ) years , with whom the disease has diagnosed by blood and marrow examination in the hospital of blood diseases in the CHU of Batna, and on 194 healthy witnesses of the same age. The two groups were benefited by a dosage of the concentration of the homocysteine vitamin B9 ,vitamin B12 , and also of the study of special polymorphisms of indispensable enzymes in the metabolism of this acid , and that by the use of the method ( Light cycler ) Real time PCR , on the following enzymes : MS ( C2756G ), MSR ( A66G ) ,MTHFR1 ( C677T ) and MTHFR2 (A1298C). The obtained results have revealed that the rate of the homozygote muted genotype is the less frequent in the two groups , and that exist at list one genotype of each enzyme in the ill group and in which the percentage exceed with remarkable way the same genotype in the healthy group and we notice specially the muted genotype GG of -the methionine synthetase-and the form TT of the enzyme – methyline tetra hydrofolate reductase – We notice the existence of considerable number of genotypes in the ill group lied with characteristic increase of this Amino-acid ,and that for the reduction of the biologic activity of these enzymes which become inefficient in the transfer of the homocysteine into the methionine and cause the diminution of the biologic activity of these enzymes and with consequence the reduction of the percentage of methylic radicals in the DNA of studied genes and that lead to the increase of the activity and the capacity of transcription , and it-s so probably that this last one is one of the factors of this disease especially if we know that the specific check-up of vitamins is normal and similar in the two groups , which ovoid the hypothesis of the reduction of vitamins . We notice also that the heterozygote genotype is the less in the sick category except the MTHFR2. Wild genotype is more frequent in the witness group except MSR. Even these results are partials; they open a new way in the genetic diagnosis of this malicious disease which allow a precocious diagnosis and the use of an effective and appropriated treatment in the same time.

Keywords: Genetic polymorphism, Acute Lymphoblastic Leukaemia, Biomarkers, Metabolism of homocystein

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1054915

References:

[1] S. Diop, R. Letestu , D. Orsolani, and Y. Lebouef ," Expression of proliferation marker Ki 67 in chroniclymphocyticleukimea". Dakar medical. Vol. 50, no. 2, pp. 65-8, 2005.
[2] J.B Dubois, « Les marqueurs tumoraux sériques De la théorie ├á la pratiqu e ». Montpellier Edition Espace . 1996.
[3] Y. Fulla, F. ana pycha,.. "Place des marqueurs tumoraux circulants dans la diagnostic et le suivie des tumeurs clorectales » . MédNucl Vol. 20, pp. 269-75, 1996.
[4] ] H. Zetterberg, B.Regland, M.Palmer, A.Ricksten, L.Plmqvist, and L.Rymo,"Increased frequency of combined methyl ntetre hydrofolate reductase C677Tand A1298C mutated allales in spontan,e ousabortedembros". Eur J Hum Genet, Vol. 10, pp. 113-8, 2002.
[5] ] PM.Ueland , S. Hustad. and J.Schneed ,"Biological and clinical implication of the MTHFR C677T polymorphism".Trends Pharmacol Sci, Vol. 22, pp. 269-272, 2001.
[6] R.F. Franco, A.G. Argio, J.F. Guerreiro, J. Elion And M.A. Zago, "Analysis of the C677T mutation of the methyl netetra hydrofolate reductase Gene in defferente thnic groups" .ThrombHeamost, Vol. 79, pp. 119-121, 1998.
[7] E. Ruud, H. Holmstrom, F.Brosstad, and F. Wesenberg. "Children with acute lymphoblastic Leukemia have high plasma levels of total homocysteineat time of diagnosis". Scandivian J Clin and Lab Invest,Vol. 66, no. 1, pp. 67-78, 2006.
[8] D.Valik, J.Sterba, V. Bajciova, and R.Demlova , "Severe encephalopathy induced by the first but not the second course of highdose methotrexate mirrored by plasma homocysteine elevation and preceded by externe differences in pretreatment plasma folate .Oncology, Vol. 69, no. 3, pp. 269-272, 2005.
[9] J.Sterba, L.Dusek, R. Demlova, and D.Valik, "Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic Leukemia and non-Hodgkin lymphoma : folateoverrescue concept revisited" .Clin Chem,Vol. 52, no. 4, pp. 692-700. 2006.
[10] D.J. Gaughan, S. Barbaux, L.A. Kluijtmans, and A.S. Whitehead, "The human and mouse Methylenetetrahydrofolatereductase (MTHFR) genes : genomic organisation , mRNA structure and linkage to the CLCN6 gene" , Gene , Vol. 257, pp. 279-89. 2000.
[11] J .Geisel, L. Zimblemann , H. Schorr, J.P. Knapp, M. Bodies, U. Hubner, and W.Hermann, "Genetic defects as important factor for moderate hyperhomocysteinema" .Clin ChemLab Med,Vol. 39, pp. 698- 704. 2001.
[12] S. Kishi, J. Griener , c.,Cheng , Das, E. Cook, D. Pei, M. Hudson, J. Rubnitz, and J. T. "Sandlund, Homocysteine, pharmacogenetics, andneurotoxicity in children with Leukemia" . J Clin Oncology, Vol. 21, no. 16, pp. 3084-3091, 2003.
[13] K . Boduroglu, Y. Alanay , B. Koldan , and E. Tunbilek , "Methylenetetra hydrofolate reductase enzyme polymorphisms as maternalrisk for Down syndrome among Turkish women" . Am J Med Genet , Vol. 127, pp. 5-10. 2004 .